Shun-Chang Ma1,2, Qi Li3, Jia-Yi Peng1, Jian-Long Zhouwen1, Jin-Fu Diao1, Jian-Xing Niu1, Xi Wang1, Xiu-Dong Guan1, Wang Jia1, Wen-Guo Jiang4. 1. Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. 2. Department of Neurosurgery, Fuxing Hospital, Capital Medical University, Beijing, China. 3. Core Laboratory for Clinical Medical Research, Beijing Tian Tan Hospital, Capital Medical University, Beijing, China. 4. Metastasis and Angiogenesis Research Group, University Department of Surgery, Cardiff University School of Medicine, Cardiff, UK.
Abstract
AIMS: To investigate the roles of Claudin-5 (CLDN5) in regulating the permeability of the blood-brain barrier (BBB) during lung cancer brain metastasis. RESULTS: By silencing and overexpressing the CLDN5 gene in human brain vascular endothelial (hCMEC/D3) cells, we demonstrated the attenuation of cell migration ability and CLDN5's significant positive role in cell proliferation in CLDN5-overexpressing hCMEC/D3 cells and observed the opposite result in the CLDN5 knockdown group. The reinforced CLDN5 expression reduced the paracellular permeability of hCMEC/D3 cells and decreased the invasion of lung adenocarcinoma A549 cells. Overall, 1685 genes were found to be differentially expressed between the CLDN5-overexpressing cells and the control cells using the Affymetrix Human Transcriptome Array 2.0 (HTA 2.0), and the function of these genes was determined by Gene Ontology and pathway analyses. The possible biological functions of the 1685 genes include cell proliferation, adhesion molecules, and the Jak-STAT, PI3K-Akt, Wnt, and Notch signaling pathways. The identified sets of mRNAs that were specific to CLDN5-overexpressing hCMEC/D3 cells were verified by a qRT-PCR experiment. CONCLUSION: CLDN5 regulates the permeability of BBB by regulating the proliferation, migration, and permeability of hCMEC/D3 cells, especially through the cell adhesion molecule signaling pathway, to enhance the function of the tight junctions, which was involved in reducing the formation of lung cancer brain metastasis.
AIMS: To investigate the roles of Claudin-5 (CLDN5) in regulating the permeability of the blood-brain barrier (BBB) during lung cancer brain metastasis. RESULTS: By silencing and overexpressing the CLDN5 gene in human brain vascular endothelial (hCMEC/D3) cells, we demonstrated the attenuation of cell migration ability and CLDN5's significant positive role in cell proliferation in CLDN5-overexpressing hCMEC/D3 cells and observed the opposite result in the CLDN5 knockdown group. The reinforced CLDN5 expression reduced the paracellular permeability of hCMEC/D3 cells and decreased the invasion of lung adenocarcinoma A549 cells. Overall, 1685 genes were found to be differentially expressed between the CLDN5-overexpressing cells and the control cells using the Affymetrix Human Transcriptome Array 2.0 (HTA 2.0), and the function of these genes was determined by Gene Ontology and pathway analyses. The possible biological functions of the 1685 genes include cell proliferation, adhesion molecules, and the Jak-STAT, PI3K-Akt, Wnt, and Notch signaling pathways. The identified sets of mRNAs that were specific to CLDN5-overexpressing hCMEC/D3 cells were verified by a qRT-PCR experiment. CONCLUSION:CLDN5 regulates the permeability of BBB by regulating the proliferation, migration, and permeability of hCMEC/D3 cells, especially through the cell adhesion molecule signaling pathway, to enhance the function of the tight junctions, which was involved in reducing the formation of lung cancer brain metastasis.
Authors: Svetlana M Stamatovic; Richard F Keep; Michael M Wang; Ivana Jankovic; Anuska V Andjelkovic Journal: J Biol Chem Date: 2009-05-07 Impact factor: 5.157
Authors: Reiner F Haseloff; Sophie Dithmer; Lars Winkler; Hartwig Wolburg; Ingolf E Blasig Journal: Semin Cell Dev Biol Date: 2014-11-26 Impact factor: 7.727
Authors: Johanna P Laakkonen; Jari P Lappalainen; Thomas L Theelen; Pyry I Toivanen; Tiina Nieminen; Suvi Jauhiainen; Minna U Kaikkonen; Judith C Sluimer; Seppo Ylä-Herttuala Journal: Angiogenesis Date: 2016-11-21 Impact factor: 9.596
Authors: B B Weksler; E A Subileau; N Perrière; P Charneau; K Holloway; M Leveque; H Tricoire-Leignel; A Nicotra; S Bourdoulous; P Turowski; D K Male; F Roux; J Greenwood; I A Romero; P O Couraud Journal: FASEB J Date: 2005-09-01 Impact factor: 5.191
Authors: Mónica Sobrado; Belén G Ramirez; Fernando Neria; Ignacio Lizasoain; Maria Lourdes Arbones; Takashi Minami; Juan Miguel Redondo; María Angeles Moro; Eva Cano Journal: J Neuroinflammation Date: 2012-03-07 Impact factor: 8.322
Authors: John C van Swieten; Bart J L Eggen; Emma Gerrits; Lucia A A Giannini; Nieske Brouwer; Shamiram Melhem; Danielle Seilhean; Isabelle Le Ber; Alwin Kamermans; Gijs Kooij; Helga E de Vries; Erik W G M Boddeke; Harro Seelaar Journal: Nat Neurosci Date: 2022-07-25 Impact factor: 28.771
Authors: Kenji J Maeda; Daniel M McClung; Kurt C Showmaker; Junie P Warrington; Michael J Ryan; Michael R Garrett; Jennifer M Sasser Journal: Am J Physiol Heart Circ Physiol Date: 2020-12-04 Impact factor: 4.733